Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer's continuum when only subtle changes in Aβ …

M Suárez‐Calvet, TK Karikari, NJ Ashton… - EMBO molecular …, 2020 - embopress.org
In Alzheimer's disease (AD), tau phosphorylation in the brain and its subsequent release
into cerebrospinal fluid (CSF) and blood is a dynamic process that changes during disease …

Neurogranin and VILIP-1 as molecular indicators of neurodegeneration in Alzheimer's disease: A systematic review and meta-analysis

M Dulewicz, A Kulczyńska-Przybik… - International journal of …, 2020 - mdpi.com
Neurogranin (Ng) and visinin-like protein 1 (VILIP-1) are promising candidates for
Alzheimer's Disease (AD) biomarkers closely related to synaptic and neuronal …

Tau and MAPT genetics in tauopathies and synucleinopathies

E Leveille, OA Ross, Z Gan-Or - Parkinsonism & related disorders, 2021 - Elsevier
MAPT encodes the microtubule-associated protein tau, which is the main component of
neurofibrillary tangles (NFTs) and found in other protein aggregates. These aggregates are …

Role of microglial cells in Alzheimer's disease tau propagation

E Španić, L Langer Horvat, PR Hof… - Frontiers in aging …, 2019 - frontiersin.org
Uncontrolled immune response in the brain contributes to the progression of all
neurodegenerative disease, including Alzheimer's disease (AD). Recent investigations have …

IL-1β, IL-6, IL-10, and TNF α single nucleotide polymorphisms in human influence the susceptibility to Alzheimer's disease pathology

M Babić Leko, M Nikolac Perković… - Journal of …, 2020 - content.iospress.com
Background: Neuroinflammation plays an important role in Alzheimer's disease (AD). During
this process, activated microglia release pro-inflammatory cytokines such as interleukin (IL) …

The MAPT H1 Haplotype Is a Risk Factor for Alzheimer's Disease in APOE ε4 Non-carriers

P Sánchez-Juan, S Moreno, I de Rojas… - Frontiers in Aging …, 2019 - frontiersin.org
An ancestral inversion of 900 kb on chromosome 17q21, which includes the microtubule-
associated protein tau (MAPT) gene, defines two haplotype clades in Caucasians (H1 and …

Total tau in cerebrospinal fluid detects treatment responders among spinal muscular atrophy types 1–3 patients treated with nusinersen

G Šimić, V Vukić, M Babić, M Banović… - CNS Neuroscience …, 2024 - Wiley Online Library
Aims Considering the substantial variability in treatment response across patients with
spinal muscular atrophy (SMA), reliable markers for monitoring response to therapy and …

A meta-analysis on the levels of VILIP-1 in the CSF of Alzheimer's disease compared to normal controls and other neurodegenerative conditions

IA Mavroudis, F Petridis, S Chatzikonstantinou… - Aging Clinical and …, 2021 - Springer
Alzheimer's disease (AD) is a progressing neurodegenerative disorder and the main cause
of serious irreversible cognitive decline in elderly people. Visinin-like protein 1 (VILIP-1) is a …

The role of frontotemporal dementia associated genes in patients with Alzheimer's disease

X Xiao, Z Yuan, L Guo, X Liao, Y Zhou, W Zhang… - Neurobiology of …, 2021 - Elsevier
Alzheimer's disease (AD) and frontotemporal dementia (FTD) overlap clinically and
pathologically. However, the role of FTD-associated genes in patients with AD remained …

Variants in PPP2R2B and IGF2BP3 are associated with higher tau deposition

VK Ramanan, X Wang, SA Przybelski… - Brain …, 2020 - academic.oup.com
Tau deposition is a key biological feature of Alzheimer's disease that is closely related to
cognitive impairment. However, it remains poorly understood why certain individuals may be …